This document summarizes evidence of sexual transmission of the Zika virus. It discusses how Zika was first discovered in 1947 and recent epidemics have shown it can cause severe birth defects. Unlike other mosquito-borne flaviviruses, Zika can be transmitted sexually. The document reviews cases of individuals who were infected after travel and outlines evidence of Zika persisting in semen and vaginal secretions, enabling sexual transmission. It emphasizes the importance of precautions during and after travel to Zika outbreak areas.
Zika Virus: Medical Countermeasure Development Challenges by Robert W. MaloneJan-Cedric Hansen
Reports of high rates of primary microcephaly and Guillain–Barré syndrome associated with Zika virus infection in French Polynesia and Brazil have raised concerns that the virus circulating in these regions is a rapidly developing neuropathic, teratogenic, emerging infec- tious public health threat. There are no licensed medical countermeasures (vaccines, thera- pies or preventive drugs) available for Zika virus infection and disease. The Pan American Health Organization (PAHO) predicts that Zika virus will continue to spread and eventually reach all countries and territories in the Americas with endemic Aedes mosquitoes. This paper reviews the status of the Zika virus outbreak, including medical countermeasure options, with a focus on how the epidemiology, insect vectors, neuropathology, virology and immunology inform options and strategies available for medical countermeasure develop- ment and deployment.
This document discusses current and emerging diagnostics for Zika virus. It begins by providing background on Zika virus and describing the clinical presentation of acute infection, which is often asymptomatic or involves mild fever, rash and joint pain. Diagnostic testing includes PCR for viral RNA in the acute phase or IgM ELISA and neutralization tests in later phases. Several commercial molecular tests for Zika virus have received regulatory approval or authorization. Emerging approaches discussed include metagenomic sequencing, nanopore sequencing, and identifying host gene expression biomarkers that could aid differential diagnosis.
Zika virus is transmitted to humans primarily through the bite of infected Aedes mosquitoes. It typically causes mild fever, rash, joint pain, and conjunctivitis lasting up to a week. While most infections are asymptomatic, Zika virus infection during pregnancy can cause microcephaly and other birth defects. The virus was first identified in 1947 and outbreaks have occurred in Africa, Asia, Pacific Islands and the Americas. There is no vaccine or specific treatment, so prevention focuses on controlling the mosquito vector and protecting against bites.
This is the first time in history that ZIKV has been associated with the development of adverse birth outcomes and has been linked to perinatal transmission. Little is known regarding the natural history, epidemiological transmission patterns, and major risk factors associated with ZIKV. Data on the outcomes of pregnancies in ZIKV infected women as well as specific trimesters when pregnant women are at highest risk for developing an adverse birth outcome remains sparse. This presentation discusses the epidemiological background and history of Zika Virus, preventative methods, and risk factors. In addition, the presentation discusses a research proposal to evaluate potential risk factors associated with the development of adverse birth outcomes in pregnant women with a laboratory confirmed diagnosis of ZIKV versus those Zika Virus infected pregnant women that did not develop adverse birth outcomes in three low-income regions of Northeastern Brazil.
This document discusses Zika virus and provides information for clinicians. It describes the epidemiology of Zika virus, including transmission and outbreaks in the Americas. It outlines the clinical presentation of Zika virus disease and discusses diagnostic testing. It also addresses maternal-fetal transmission of Zika virus and the relationship between Zika virus infection during pregnancy and microcephaly in infants.
Advisor Live: Zika virus disease – What you need to knowPremier Inc.
Presented as part of Premier’s AdvisorLive® series and co-sponsored by the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC)
This webinar covers:
* Updates and late breaking information on Zika virus outbreak, lab diagnosis and travel,
* Issues for reproductive age and pregnant women, including evaluation, management, counseling, and congenital findings, and
* Implications and risks for healthcare personnel.
EXPERT PRESENTERS:
* Joanne Cono, MD, ScM, Director, Office of Science Quality, Office of the Director, Centers for Disease Control and Prevention (CDC)
* Jeanne S. Sheffield, MD, Director of Maternal-Fetal Medicine and Professor, Johns Hopkins Medicine
* Moderator: Gina Pugliese, RN, MS, Vice President, Premier Safety Institute
Transfusion transmitted ZIKV: BSRI/UCSF/UCD studies to safeguard the global b...UCSFGlobalHealthSciences
1) Studies led by BSRI/UCSF aim to safeguard the global blood supply from Zika virus transmission by characterizing viral and immune markers in infected blood donors. Repositories of samples from donors and recipients will help understand Zika virus epidemiology, infectivity, and pathogenesis.
2) Case-control studies of over 3,500 Brazilian transfusion recipients will determine Zika virus and other arbovirus infection rates and evaluate symptoms in infected recipients. Testing over 16,000 Brazilian blood donor samples will provide data on Zika virus, Chikungunya virus, and dengue virus viremia rates in donors.
3) A study of 1,500 pregnant Brazilian women will characterize Zika
Zika Virus: Medical Countermeasure Development Challenges by Robert W. MaloneJan-Cedric Hansen
Reports of high rates of primary microcephaly and Guillain–Barré syndrome associated with Zika virus infection in French Polynesia and Brazil have raised concerns that the virus circulating in these regions is a rapidly developing neuropathic, teratogenic, emerging infec- tious public health threat. There are no licensed medical countermeasures (vaccines, thera- pies or preventive drugs) available for Zika virus infection and disease. The Pan American Health Organization (PAHO) predicts that Zika virus will continue to spread and eventually reach all countries and territories in the Americas with endemic Aedes mosquitoes. This paper reviews the status of the Zika virus outbreak, including medical countermeasure options, with a focus on how the epidemiology, insect vectors, neuropathology, virology and immunology inform options and strategies available for medical countermeasure develop- ment and deployment.
This document discusses current and emerging diagnostics for Zika virus. It begins by providing background on Zika virus and describing the clinical presentation of acute infection, which is often asymptomatic or involves mild fever, rash and joint pain. Diagnostic testing includes PCR for viral RNA in the acute phase or IgM ELISA and neutralization tests in later phases. Several commercial molecular tests for Zika virus have received regulatory approval or authorization. Emerging approaches discussed include metagenomic sequencing, nanopore sequencing, and identifying host gene expression biomarkers that could aid differential diagnosis.
Zika virus is transmitted to humans primarily through the bite of infected Aedes mosquitoes. It typically causes mild fever, rash, joint pain, and conjunctivitis lasting up to a week. While most infections are asymptomatic, Zika virus infection during pregnancy can cause microcephaly and other birth defects. The virus was first identified in 1947 and outbreaks have occurred in Africa, Asia, Pacific Islands and the Americas. There is no vaccine or specific treatment, so prevention focuses on controlling the mosquito vector and protecting against bites.
This is the first time in history that ZIKV has been associated with the development of adverse birth outcomes and has been linked to perinatal transmission. Little is known regarding the natural history, epidemiological transmission patterns, and major risk factors associated with ZIKV. Data on the outcomes of pregnancies in ZIKV infected women as well as specific trimesters when pregnant women are at highest risk for developing an adverse birth outcome remains sparse. This presentation discusses the epidemiological background and history of Zika Virus, preventative methods, and risk factors. In addition, the presentation discusses a research proposal to evaluate potential risk factors associated with the development of adverse birth outcomes in pregnant women with a laboratory confirmed diagnosis of ZIKV versus those Zika Virus infected pregnant women that did not develop adverse birth outcomes in three low-income regions of Northeastern Brazil.
This document discusses Zika virus and provides information for clinicians. It describes the epidemiology of Zika virus, including transmission and outbreaks in the Americas. It outlines the clinical presentation of Zika virus disease and discusses diagnostic testing. It also addresses maternal-fetal transmission of Zika virus and the relationship between Zika virus infection during pregnancy and microcephaly in infants.
Advisor Live: Zika virus disease – What you need to knowPremier Inc.
Presented as part of Premier’s AdvisorLive® series and co-sponsored by the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC)
This webinar covers:
* Updates and late breaking information on Zika virus outbreak, lab diagnosis and travel,
* Issues for reproductive age and pregnant women, including evaluation, management, counseling, and congenital findings, and
* Implications and risks for healthcare personnel.
EXPERT PRESENTERS:
* Joanne Cono, MD, ScM, Director, Office of Science Quality, Office of the Director, Centers for Disease Control and Prevention (CDC)
* Jeanne S. Sheffield, MD, Director of Maternal-Fetal Medicine and Professor, Johns Hopkins Medicine
* Moderator: Gina Pugliese, RN, MS, Vice President, Premier Safety Institute
Transfusion transmitted ZIKV: BSRI/UCSF/UCD studies to safeguard the global b...UCSFGlobalHealthSciences
1) Studies led by BSRI/UCSF aim to safeguard the global blood supply from Zika virus transmission by characterizing viral and immune markers in infected blood donors. Repositories of samples from donors and recipients will help understand Zika virus epidemiology, infectivity, and pathogenesis.
2) Case-control studies of over 3,500 Brazilian transfusion recipients will determine Zika virus and other arbovirus infection rates and evaluate symptoms in infected recipients. Testing over 16,000 Brazilian blood donor samples will provide data on Zika virus, Chikungunya virus, and dengue virus viremia rates in donors.
3) A study of 1,500 pregnant Brazilian women will characterize Zika
This presentation summarizes what we know as of 10/27/16 about the connection between Zika virus and microcephaly, and what advice physicians could provide for their patients who are currently pregnant, or planning a pregnancy
This document summarizes information about the Zika virus. It describes how Zika is transmitted by Aedes mosquitoes, causes a mild fever in most cases but can also result in Guillain-Barre syndrome and birth defects. Recent large outbreaks have occurred in French Polynesia, Brazil and the Americas. There is no vaccine and diagnosis involves virus detection or antibody testing. Protection from mosquito bites is recommended.
The Zika virus was discovered in Africa in 1947 and can cause mild illness, but its emergence in the Americas has coincided with a marked increase in microcephaly. Microcephaly is a birth defect where the baby's head is much smaller than expected and is associated with problems in brain development. Studies of the Zika outbreak in French Polynesia from 2013-2014 found that the risk of microcephaly was about 1% for mothers infected during the first trimester of pregnancy. While this risk appears low, a very high percentage of people were infected during Zika outbreaks, so it remains an important public health issue despite the relatively low risk for any individual fetus.
The document provides information on the Zika virus, including its history, epidemiology, transmission, signs and symptoms, complications, diagnosis, and current situation. It discusses how the virus was first identified in 1947 in Uganda in monkeys and humans in 1952. It outlines its spread to Africa, Asia, the Pacific islands, and the Americas. It also summarizes Brazil reporting over 500,000 suspected Zika cases and the observed increase in Guillain-Barré syndrome and microcephaly linked to the outbreak.
Zika virus is transmitted by daytime-active Aedes mosquitoes and can cause mild fever and rash in humans. It emerged as a global health concern in 2015 when infection during pregnancy was linked to microcephaly and other birth defects. There is no vaccine or treatment, so prevention focuses on avoiding mosquito bites.
McNair Poster Board Presentation. Isaacson MichelIsaacson Michel
The author thanks the McNair Scholars Program and their faculty advisor, Dr. Summer Hawkins, for their support in developing a research topic on comparing Brazil and US policies and prevention measures for the Zika virus. References are provided from sources like the CDC, WHO, and medical journals. The author's research questions examine the different responses in Brazil and the US to the Zika outbreak, effects on international travel, and comparisons of case numbers before and after the Olympics.
This document discusses Zika virus and provides information about diagnosis and treatment. It begins with two pre-test questions about advising individuals who may have been exposed to Zika virus. The rest of the document summarizes key details about Zika virus, including its history, transmission, clinical manifestations, diagnosis, evaluation of pregnant women exposed, and treatment approaches. Zika virus is an emerging infectious disease that spreads through mosquito bites and can cause microcephaly in babies born to infected mothers. Diagnosis involves laboratory testing of blood and other samples. Evaluation and monitoring of pregnant women exposed focuses on fetal ultrasound screening. Treatment is generally rest, fluids, and acetaminophen.
This document provides an overview of the Zika virus. It begins with definitions and an introduction to the virus. The history section describes its discovery and spread. Key points include it being first isolated in 1947 in Uganda and recent outbreaks in French Polynesia, Brazil, and other Americas countries. The rest of the document covers epidemiology, clinical features, diagnosis, treatment, prevention, and control of the Zika virus. It provides details on transmission, symptoms, complications like Guillain-Barré syndrome, diagnostic testing, current lack of vaccines or treatment, and recommendations to prevent mosquito bites.
Zika virus poses risks to communities in Puerto Rico and parts of the US. Community health centers are responding by screening pregnant patients, educating communities on risks and prevention, and distributing prevention kits. The National Association of Community Health Centers can help by providing educational materials, lobbying for vaccine development, and raising awareness among clinicians. Coordinated responses are needed due to the threat of local transmission and travel between high-risk areas.
Zika virus is transmitted primarily through the bite of infected Aedes mosquitoes and can cause fever, rash, joint pain, and conjunctivitis. While usually mild, Zika virus infection during pregnancy can cause microcephaly and other birth defects. The virus was first identified in 1947 and outbreaks have recently occurred in Brazil, the Americas, and the Pacific. Diagnosis involves virus detection or antibody testing, but results can be complicated by cross-reactivity with other flaviviruses like dengue.
This document summarizes information about Zika virus infection in pregnancy from several sources:
- Zika virus is transmitted by Aedes mosquitoes and was first isolated in Uganda in 1947. Recent outbreaks have occurred in French Polynesia, Brazil and other parts of the Americas.
- Brazil reported an increase in infants born with microcephaly in 2015 which was linked to Zika virus infection during pregnancy after the virus was detected in amniotic fluid and brain tissue of affected fetuses and infants.
- The CDC provides testing and screening guidelines for pregnant women with travel history or residence in areas with Zika virus transmission to monitor infections and potential fetal impact.
Zika virus was first isolated in 1947 in Uganda. It is transmitted primarily via Aedes mosquitoes and can cause microcephaly and other birth defects. There was an outbreak in Brazil in 2015-2016 which spread rapidly through the Americas. Pregnant women who travel to affected areas are advised to strictly follow steps to prevent mosquito bites. Testing involves RT-PCR of serum and urine within 2 weeks of symptoms, and IgM antibody testing if RT-PCR is negative. Interpretation of results must consider cross-reactivity with other flaviviruses.
This document discusses SARS-CoV-2 variants and their impact. It identifies four main variants of concern (VOCs): B.1.1.7, B.1.351, P.1, and Cluster 5. These variants show evidence of increased transmissibility and have had impacts on diagnostics and public health measures. Sequencing data has been important for identifying VOCs and monitoring their spread and effects. Ongoing surveillance of new variants is needed to understand future impacts on diagnostics, disease spread, and vaccine effectiveness.
BCC Activities Regarding HIV/AIDS Awareness Dr munawar urduDr Munawar Khan
Dr. M. MUNAWAR KHAN is the BCC Coordinator of the Sindh AIDS Control Program. The document outlines key factors leading to the spread of HIV/AIDS in Sindh, including unscreened blood transfusions, transmission from mother to child, and sharing of syringes. It identifies target groups at high risk such as transport workers, immigrants, sex workers, jail inmates, beggars, and addicts. The campaign objectives are to create awareness of HIV/AIDS, influence behavior change through education, encourage discussion of safe sexual practices, and reduce the social stigma around the disease. A key issue discussed is the lack of mandatory blood screening and scarce voluntary blood donations in Sindh
Zika virus disease is a mosquito-borne viral infection that primarily occurs in tropical and subtropical areas of the world.
It is related to other pathogenic vector borne flaviviruses including dengue, West-Nile and Japanese encephalitis viruses but produces a comparatively mild disease in humans
Genre: Flavivirus
Vector: Aedes mosquitoes (which usually bite during the morning and late afternoon/evening hours)
Reservoir: mosquitoes (gut, blood, saliva )
human ( blood, prostate, semen and testes )
The document summarizes information about Zika virus including its structure, taxonomy, genome, replication cycle, transmission, signs and symptoms, diagnosis, treatment and prevention. It describes Zika virus as a flavivirus transmitted by Aedes mosquitoes that can cause mild fever and rash. The document highlights the association between Zika infection in pregnant women and microcephaly in babies. It provides details on detecting the virus in different samples like serum, urine and semen using RT-PCR and challenges in diagnosis. The need for public alerts, travel guidance and testing is emphasized.
Zika virus was first isolated in 1947 from a monkey in the Zika Forest of Uganda. It is transmitted primarily via Aedes mosquito bites. While most infections cause mild symptoms or none, it poses a serious threat during pregnancy as it can cause microcephaly and other birth defects. There are currently no vaccines or treatments available. Diagnosis is typically via RT-PCR testing of blood or other samples.
The document discusses Brazil's experiences with the Zika virus outbreak in Pernambuco from 2015-2016. It describes how an initial outbreak of rash was later confirmed to be Zika virus in July 2015. Later that year, cases of Guillain-Barré syndrome and microcephaly in newborns increased, associated with Zika infections months prior. Surveillance efforts successfully monitored the outbreak through syndromic and universal case reporting, as well as sentinel laboratory testing of pregnant women and newborns. Challenges remained in differentiating Zika from other co-circulating viruses like dengue and chikungunya.
The document summarizes information about the Zika virus. It discusses how the World Health Organization declared Zika a public health emergency due to its suspected link to microcephaly. It then provides details about the symptoms of Zika virus, how it is transmitted, diagnosed, prevented, and treated. The document also discusses the WHO and CDC responses to Zika and efforts to develop a vaccine.
Neurological and Autoimmune Complications of Zika Virus infection - Slideset ...WAidid
The slideset by Professor Safadi analyses the case control study providing evidence for Zika virus infection causing Guillain-Barré syndrome.
In addition to Zika Virus association with Guillain-Barré syndrome, the slides show new data from endemic areas suggesting that ZIKV may be linked to other neurological outcomes.
The document summarizes the ongoing Zika virus outbreak, providing background on its origins and spread. It describes how the virus was first isolated in Uganda in 1947 and caused isolated outbreaks until emerging in Brazil in 2014. The rapid spread in Brazil and other South and Central American countries prompted the WHO to declare a global health emergency in 2016 due to links between Zika infection in pregnant women and microcephaly in babies. The summary highlights several key points, including new transmission vectors like sexual contact and bloodborne transmission that complicate containment efforts.
Zika virus is spread by daytime-active Aedes mosquitoes and often causes mild or no symptoms. It was isolated in Uganda in 1947 and has recently spread to areas in the Americas. The virus is associated with microcephaly in fetuses when the mother is infected during pregnancy and Guillain-Barré syndrome in adults. While medications and vaccines are currently unavailable, health organizations recommend precautions for pregnant women such as postponing travel to affected areas.
This presentation summarizes what we know as of 10/27/16 about the connection between Zika virus and microcephaly, and what advice physicians could provide for their patients who are currently pregnant, or planning a pregnancy
This document summarizes information about the Zika virus. It describes how Zika is transmitted by Aedes mosquitoes, causes a mild fever in most cases but can also result in Guillain-Barre syndrome and birth defects. Recent large outbreaks have occurred in French Polynesia, Brazil and the Americas. There is no vaccine and diagnosis involves virus detection or antibody testing. Protection from mosquito bites is recommended.
The Zika virus was discovered in Africa in 1947 and can cause mild illness, but its emergence in the Americas has coincided with a marked increase in microcephaly. Microcephaly is a birth defect where the baby's head is much smaller than expected and is associated with problems in brain development. Studies of the Zika outbreak in French Polynesia from 2013-2014 found that the risk of microcephaly was about 1% for mothers infected during the first trimester of pregnancy. While this risk appears low, a very high percentage of people were infected during Zika outbreaks, so it remains an important public health issue despite the relatively low risk for any individual fetus.
The document provides information on the Zika virus, including its history, epidemiology, transmission, signs and symptoms, complications, diagnosis, and current situation. It discusses how the virus was first identified in 1947 in Uganda in monkeys and humans in 1952. It outlines its spread to Africa, Asia, the Pacific islands, and the Americas. It also summarizes Brazil reporting over 500,000 suspected Zika cases and the observed increase in Guillain-Barré syndrome and microcephaly linked to the outbreak.
Zika virus is transmitted by daytime-active Aedes mosquitoes and can cause mild fever and rash in humans. It emerged as a global health concern in 2015 when infection during pregnancy was linked to microcephaly and other birth defects. There is no vaccine or treatment, so prevention focuses on avoiding mosquito bites.
McNair Poster Board Presentation. Isaacson MichelIsaacson Michel
The author thanks the McNair Scholars Program and their faculty advisor, Dr. Summer Hawkins, for their support in developing a research topic on comparing Brazil and US policies and prevention measures for the Zika virus. References are provided from sources like the CDC, WHO, and medical journals. The author's research questions examine the different responses in Brazil and the US to the Zika outbreak, effects on international travel, and comparisons of case numbers before and after the Olympics.
This document discusses Zika virus and provides information about diagnosis and treatment. It begins with two pre-test questions about advising individuals who may have been exposed to Zika virus. The rest of the document summarizes key details about Zika virus, including its history, transmission, clinical manifestations, diagnosis, evaluation of pregnant women exposed, and treatment approaches. Zika virus is an emerging infectious disease that spreads through mosquito bites and can cause microcephaly in babies born to infected mothers. Diagnosis involves laboratory testing of blood and other samples. Evaluation and monitoring of pregnant women exposed focuses on fetal ultrasound screening. Treatment is generally rest, fluids, and acetaminophen.
This document provides an overview of the Zika virus. It begins with definitions and an introduction to the virus. The history section describes its discovery and spread. Key points include it being first isolated in 1947 in Uganda and recent outbreaks in French Polynesia, Brazil, and other Americas countries. The rest of the document covers epidemiology, clinical features, diagnosis, treatment, prevention, and control of the Zika virus. It provides details on transmission, symptoms, complications like Guillain-Barré syndrome, diagnostic testing, current lack of vaccines or treatment, and recommendations to prevent mosquito bites.
Zika virus poses risks to communities in Puerto Rico and parts of the US. Community health centers are responding by screening pregnant patients, educating communities on risks and prevention, and distributing prevention kits. The National Association of Community Health Centers can help by providing educational materials, lobbying for vaccine development, and raising awareness among clinicians. Coordinated responses are needed due to the threat of local transmission and travel between high-risk areas.
Zika virus is transmitted primarily through the bite of infected Aedes mosquitoes and can cause fever, rash, joint pain, and conjunctivitis. While usually mild, Zika virus infection during pregnancy can cause microcephaly and other birth defects. The virus was first identified in 1947 and outbreaks have recently occurred in Brazil, the Americas, and the Pacific. Diagnosis involves virus detection or antibody testing, but results can be complicated by cross-reactivity with other flaviviruses like dengue.
This document summarizes information about Zika virus infection in pregnancy from several sources:
- Zika virus is transmitted by Aedes mosquitoes and was first isolated in Uganda in 1947. Recent outbreaks have occurred in French Polynesia, Brazil and other parts of the Americas.
- Brazil reported an increase in infants born with microcephaly in 2015 which was linked to Zika virus infection during pregnancy after the virus was detected in amniotic fluid and brain tissue of affected fetuses and infants.
- The CDC provides testing and screening guidelines for pregnant women with travel history or residence in areas with Zika virus transmission to monitor infections and potential fetal impact.
Zika virus was first isolated in 1947 in Uganda. It is transmitted primarily via Aedes mosquitoes and can cause microcephaly and other birth defects. There was an outbreak in Brazil in 2015-2016 which spread rapidly through the Americas. Pregnant women who travel to affected areas are advised to strictly follow steps to prevent mosquito bites. Testing involves RT-PCR of serum and urine within 2 weeks of symptoms, and IgM antibody testing if RT-PCR is negative. Interpretation of results must consider cross-reactivity with other flaviviruses.
This document discusses SARS-CoV-2 variants and their impact. It identifies four main variants of concern (VOCs): B.1.1.7, B.1.351, P.1, and Cluster 5. These variants show evidence of increased transmissibility and have had impacts on diagnostics and public health measures. Sequencing data has been important for identifying VOCs and monitoring their spread and effects. Ongoing surveillance of new variants is needed to understand future impacts on diagnostics, disease spread, and vaccine effectiveness.
BCC Activities Regarding HIV/AIDS Awareness Dr munawar urduDr Munawar Khan
Dr. M. MUNAWAR KHAN is the BCC Coordinator of the Sindh AIDS Control Program. The document outlines key factors leading to the spread of HIV/AIDS in Sindh, including unscreened blood transfusions, transmission from mother to child, and sharing of syringes. It identifies target groups at high risk such as transport workers, immigrants, sex workers, jail inmates, beggars, and addicts. The campaign objectives are to create awareness of HIV/AIDS, influence behavior change through education, encourage discussion of safe sexual practices, and reduce the social stigma around the disease. A key issue discussed is the lack of mandatory blood screening and scarce voluntary blood donations in Sindh
Zika virus disease is a mosquito-borne viral infection that primarily occurs in tropical and subtropical areas of the world.
It is related to other pathogenic vector borne flaviviruses including dengue, West-Nile and Japanese encephalitis viruses but produces a comparatively mild disease in humans
Genre: Flavivirus
Vector: Aedes mosquitoes (which usually bite during the morning and late afternoon/evening hours)
Reservoir: mosquitoes (gut, blood, saliva )
human ( blood, prostate, semen and testes )
The document summarizes information about Zika virus including its structure, taxonomy, genome, replication cycle, transmission, signs and symptoms, diagnosis, treatment and prevention. It describes Zika virus as a flavivirus transmitted by Aedes mosquitoes that can cause mild fever and rash. The document highlights the association between Zika infection in pregnant women and microcephaly in babies. It provides details on detecting the virus in different samples like serum, urine and semen using RT-PCR and challenges in diagnosis. The need for public alerts, travel guidance and testing is emphasized.
Zika virus was first isolated in 1947 from a monkey in the Zika Forest of Uganda. It is transmitted primarily via Aedes mosquito bites. While most infections cause mild symptoms or none, it poses a serious threat during pregnancy as it can cause microcephaly and other birth defects. There are currently no vaccines or treatments available. Diagnosis is typically via RT-PCR testing of blood or other samples.
The document discusses Brazil's experiences with the Zika virus outbreak in Pernambuco from 2015-2016. It describes how an initial outbreak of rash was later confirmed to be Zika virus in July 2015. Later that year, cases of Guillain-Barré syndrome and microcephaly in newborns increased, associated with Zika infections months prior. Surveillance efforts successfully monitored the outbreak through syndromic and universal case reporting, as well as sentinel laboratory testing of pregnant women and newborns. Challenges remained in differentiating Zika from other co-circulating viruses like dengue and chikungunya.
The document summarizes information about the Zika virus. It discusses how the World Health Organization declared Zika a public health emergency due to its suspected link to microcephaly. It then provides details about the symptoms of Zika virus, how it is transmitted, diagnosed, prevented, and treated. The document also discusses the WHO and CDC responses to Zika and efforts to develop a vaccine.
Neurological and Autoimmune Complications of Zika Virus infection - Slideset ...WAidid
The slideset by Professor Safadi analyses the case control study providing evidence for Zika virus infection causing Guillain-Barré syndrome.
In addition to Zika Virus association with Guillain-Barré syndrome, the slides show new data from endemic areas suggesting that ZIKV may be linked to other neurological outcomes.
The document summarizes the ongoing Zika virus outbreak, providing background on its origins and spread. It describes how the virus was first isolated in Uganda in 1947 and caused isolated outbreaks until emerging in Brazil in 2014. The rapid spread in Brazil and other South and Central American countries prompted the WHO to declare a global health emergency in 2016 due to links between Zika infection in pregnant women and microcephaly in babies. The summary highlights several key points, including new transmission vectors like sexual contact and bloodborne transmission that complicate containment efforts.
Zika virus is spread by daytime-active Aedes mosquitoes and often causes mild or no symptoms. It was isolated in Uganda in 1947 and has recently spread to areas in the Americas. The virus is associated with microcephaly in fetuses when the mother is infected during pregnancy and Guillain-Barré syndrome in adults. While medications and vaccines are currently unavailable, health organizations recommend precautions for pregnant women such as postponing travel to affected areas.
Zika virus is an emerging mosquito-borne virus that is causing an alarming outbreak. It is transmitted primarily through the bite of infected Aedes mosquitoes. The current outbreak in Brazil is alarming because it is linked to a surge in microcephaly cases and Guillain-Barré syndrome. Pregnant women are advised to avoid travel to affected areas due to the risk of maternal-fetal transmission and birth defects. Public health officials recommend mosquito bite prevention and testing of pregnant women with a history of travel to affected regions.
Zika virus is an emerging mosquito-borne virus that is causing an alarming outbreak. It is transmitted primarily through the bite of infected Aedes mosquitoes. The current outbreak in Brazil is alarming because it is linked to a surge in microcephaly cases in newborns. Pregnant women are advised to avoid travel to affected areas due to the risk of maternal-fetal transmission and potential birth defects. Public health officials are working to understand and contain the outbreak.
ZIKA VIRUS Sensitization for Faculty and students by Department Of Medicine S...SMS MEDICAL COLLEGE
The current outbreak of Zika virus in Jaipur, India has rekindled national and international interest in this mosquito-borne illness. Zika virus causes a mild fever but can also result in serious neurological complications like Guillain-Barré syndrome and microcephaly in infants born to infected mothers. While the illness is usually self-limiting, the recent outbreak in Jaipur of 29 reported cases in one month requires a task force to prevent further spread.
MERS is a viral respiratory illness caused by a beta coronavirus called MERS-CoV. It was first reported in Saudi Arabia in 2012 and has since spread to several other countries. Research has found that the virus transmits between humans and dromedary camels. Camels are believed to be the main animal reservoir for MERS-CoV. With millions of pilgrims expected to visit Mecca and Medina for Hajj, there are concerns about the potential spread of MERS during this pilgrimage and measures are being taken to help prevent transmission. Currently there is no vaccine for MERS.
This document discusses filoviruses, which cause viral hemorrhagic fevers such as Ebola virus disease and Marburg virus disease. It provides background on the classification and transmission of filoviruses, describing how they are spread through contact with bodily fluids. Symptoms are then explained, which include fever, vomiting, and bleeding. As there is no vaccine or cure, treatment focuses on supportive care. The document concludes by reviewing the history of Ebola virus outbreaks since 1976 and discusses current concerns around controlling the ongoing 2014 outbreak in West Africa.
The document provides a risk assessment of a potential Zika virus outbreak in the WHO African region. It analyzed hazards, exposures, vulnerabilities and coping capacities to develop a risk ranking of countries. Key indicators included Zika transmission factors, urbanization, connectivity, treatment seeking, and government and laboratory capacities. Maps in an annex show the distribution of these indicators. The analysis aims to inform prevention and preparedness efforts for a potential Zika outbreak in Africa.
Zika virus is spread primarily through the bites of infected Aedes species mosquitoes. While most people infected with Zika virus do not develop symptoms, it can cause mild fever and rash. The main concern is that Zika infection during pregnancy can cause microcephaly and other severe brain defects in babies. There is no vaccine currently available to prevent Zika virus infection.
The presentation discusses the Zika virus. It provides an overview of the virus's history, symptoms, transmission, treatment and prevention. The virus is spread primarily via mosquito bites and can cause birth defects if contracted during pregnancy. While symptoms are often mild, it poses neurological risks. Currently, prevention focuses on avoiding mosquito bites and protected sexual contact for those in affected areas. Further research is ongoing to develop a vaccine.
Zika virus is transmitted by daytime-active Aedes mosquitoes and was first isolated in 1947 in Uganda. It causes a mild illness with symptoms like fever, rash, joint pain, and conjunctivitis lasting 2-7 days. There is no vaccine or specific treatment, though symptoms can be treated with rest, fluids, and common fever and pain medications. The virus has recently spread explosively and is a concern due to links to birth defects like microcephaly. Ongoing research aims to develop vaccines to address this emerging public health threat.
Epidemiology is defined as the study of occurrence.docxwrite22
1. Epidemiology is defined as the study of occurrence and distribution of health-related states and events in populations, including determinants that influence these states.
2. Ebola virus disease is a deadly disease caused by Ebolavirus that commonly affects people and primates. It was first discovered in 1976 in the Democratic Republic of Congo and has caused several outbreaks in central and west Africa.
3. The largest Ebola outbreak occurred from 2014-2016 in West Africa, with over 28,000 cases and 11,000 deaths. The outbreak began with an infected child in Guinea and spread to other countries before being contained.
AbstractThe Zika virus arrived within the United States, via mos.docxransayo
Abstract
The Zika virus arrived within the United States, via mosquitoes that unfold it in 2 areas in Miami-Dade County, FL, and therefore the federal agency advising pregnant girls to avoid them.
The virus causes birth defects in babies born to some infected pregnant girls, together with microcephalus, wherever babies are born with underdeveloped heads and brain injury. Zika has additionally been coupled to Landry's paralysis, a condition within which the system attacks the nerves. It’s chiefly unfold through mosquitoes, though some cases of sexual transmission are according to The Miami neighborhood of Wynwood (2009), became the primary within the U.S. wherever Zika was spreading domestically. Though a federal agency travel consulted for that space has been raised, pregnant girls are still urged to avoid a four.5-square-mile space of Miami Beach and another space of a few area unit in Miami-Dade County.
Pregnant girls and their partners UN agency sleep in the areas or should travel them ought to avoid dipteran bites. The federal agency has additionally issued travel warnings for pregnant girls in countries wherever the wellness is spreading.
The Zika virus, initial known in Republic of Uganda in 1947, is transmitted by genus Aides mosquitoes, an equivalent form of dipteran that carries infectious disease, black vomit, and chikungunya virus. A dipteran bites associate infected person and so passes those viruses to people it bites. Outbreaks didn't occur outside of continent till 2007, once it unfold to the Pacific Ocean. Zika has “never been thought of as a severe communicable disease yet,” says Amesh Adalja, MD, a spokesperson for the Infectious Diseases Society of America (2011).
The federal agency has confirmed Zika will unfold through sex, typically once someone traveled to a section wherever Zika has broken out, got the virus, and gave the virus to a sex partner UN agency didn't travel. Infected girls and men will each pass the virus to sex partners -- even though they haven’t shown symptoms of infection, the federal agency says (Duffy et al., 2009). Additionally, infected pregnant girls will pass the virus on to their vertebrate.
Research paper Zika
Some studies have additionally shown the virus is found in blood, semen, urine, and spit of infected individuals, still as in fluids within the eye. In Utah, someone got the virus while not traveling or having sexual contact. The person was a relative associated caregiver of a senior Zika patient UN agency died in late Gregorian calendar month -- the primary Zika-linked death within the U.S. The deceased man had traveled to a section wherever Zika is spreading, and science laboratory tests showed high amounts of the virus in his blood -- quite a hundred times on top of that seen in alternative samples of infected individuals, the federal agency says (Duffy et al., 2009). He additionally had associate underlying medical condition that has not been disclosed. Health officers believe .
Zika virus is a mosquito-borne virus that causes mild fever and rash. It was first discovered in Uganda in 1947 and recent outbreaks have occurred in the Americas. The virus is transmitted primarily through the bites of infected Aedes mosquitoes. While most infections cause mild symptoms, infection during pregnancy can cause microcephaly and other birth defects. There is no vaccine or treatment currently available, so prevention focuses on reducing mosquito habitat and exposure through clothing and repellents.
Knowledge and Prevalence of HIV/Aids among Suya Vendors in Kafanchan of Jema’...IIJSRJournal
This study was carried out on knowledge and prevalence of hiv/aids among suya vendors in kafanchan of jema’a local government area of kaduna state. To achieve this objective, the researcher developed and administered a questionnaire on eighty respondents. The likert scale statistical and graphical method was used in testing the null hypothesis. From the study, It was observed that The society or public authority do not educate Suya Vendors about Hiv/Aids. Economic status and educational background among Suya Vendors do not determine their knowledge of Hiv/Aids. It was also discovered that parents, religious leaders or government responsible for Hiv/Aids among Suya Vendors. It was observed that that All Suya Vendors are not knowledgeable about their Hiv Status. It was also observed that Suya Vendors negligent in knowing their status. that Suya Vendors do not tell their sexual partners about their Hiv Status. That Suya Vendors have multiple sexual partners. Both the state and federal government should take on joint projects to combat AIDS at the border areas. Projects including training, counselling, public meeting and rallies may be undertaken for awareness-building to this effect. The government should set up blood testing centre across that will be easily accessible, so that the people at Kafanchan municipal areas can get free access to HIV/AIDS testing. Educational Programmes about safe sex should be provided to the illiterate mass. Radio, TV programmes, visual aids and multimedia on AIDS should be produced to augment their awareness level.
This document provides an overview of the Ebola virus outbreak in West Africa as of April 18, 2014. It summarizes the situation in Guinea and Liberia, where confirmed Ebola cases have been reported. In Guinea, there have been a total of 197 clinical cases and 122 deaths reported. In Liberia, there have been 27 clinical cases and 13 deaths reported. The response has included contact tracing, case isolation and management, training for health workers, and social mobilization efforts. Challenges include limited health resources, infection control issues, and the need to improve community awareness as the outbreak continues.
The document discusses emerging and re-emerging infectious diseases, their causes, examples, and strategies for prevention and control. Emerging diseases are caused by new pathogens while re-emerging diseases were previously controlled but have risen again. Factors contributing to emergence include human behavior, travel, microbial adaptation, and breakdown of public health measures. Examples provided include SARS, H1N1 influenza, Ebola, Zika, and Nipah virus. Prevention strategies involve controlling reservoirs, interrupting transmission, protecting susceptible populations, strengthening surveillance, and encouraging research. Public health authorities and doctors play key roles in awareness,
Three years ago, the Zika virus was nowhere to be found in the Western Hemisphere. But in 2015, Brazil suddenly found itself in the throes of an unprecedented Zika outbreak — with more than a million people infected by the mosquito-transmitted disease
This document summarizes the history and current understanding of the AIDS epidemic. It discusses how AIDS has become one of the most studied diseases and our understanding of its medical and social drivers has deepened over time. However, the impacts are still unfolding over generations and varying significantly between places. While early models predicted severe economic impacts, some hard-hit countries have maintained growth. Understanding the social impacts remains challenging given the epidemic is only 25 years old.
Zika virus is a mosquito-borne virus first identified in Uganda in 1947. It causes mild fever and rash in most cases but has been linked to Guillain-Barré syndrome and microcephaly. The virus spread out of Africa and Asia, causing major outbreaks in French Polynesia in 2013 and Brazil in 2015. It is transmitted primarily by Aedes mosquitoes. While most cases are mild, the virus can be transmitted from mother to fetus during pregnancy and cause birth defects like microcephaly. There is no vaccine or treatment currently available, so prevention focuses on controlling mosquito populations and protecting against bites.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
2. Hastings and Fikrig: Zika virus and sexual transmission326
of Micronesia, with 49 confirmed symptomatic cases and
73 percent of the population shown to be seropositive
[16,17]. Since this first major outbreak, subsequent out-
breaks have been reported throughout the Pacific area, in
French Polynesia [18], New Caledonia, the Cook Islands,
and Easter Island [19]. Most recently, a large epidemic in
Brazil and spreading to other countries in South and Cen-
tral America and the Caribbean, has affected well over
two million people [20]. Interestingly, travel to Brazil
from epidemic areas for the 2014 World Cup [21] and the
2014 Va’a World Sprint Championship canoe race [22]
have been suggested as possible routes of transmission
for this outbreak.
Before these recent epidemics, Zika virus has pre-
sented as a relatively mild Dengue-like disease, with fe-
ver, cutaneous rash, malaise and headache that usually re-
solves in around seven days [23,24], and up to 80 percent
of infections appear to be asymptomatic [16]. These new
epidemics, however, have come with significantly more
severe symptoms including Guillain-Barre syndrome
(GBS), marked by subacute flaccid paralysis [25,26], and
congenital deformities and neurologic syndromes in new-
borns. Birth defects have been attributed to this virus in
at least 28 countries according to the WHO [27-29]. This
has led to warnings to pregnant women to be mindful of
insect repellant use and to limit travel to epidemic areas
[30]. Overall, this seeming increase in disease severity
and rapid spread has led to increasing alarm across the
globe.
For Zika virus, the main mosquito vector is the Ae-
des aegypti species, which is endemic in the southeastern
United States [31], and to a lesser extent the Aedes al-
bopictus species, which has a more temperate range [32].
With the increase of global trade and range expansion of
important insect vectors that carry these viruses, the risk
for global epidemics has greatly intensified over recent
years and appears poised to continue increasing [33-36].
The vector capacity for Zika is very similar to dengue
virus, which is estimated to infect close to 400 million
people every year [37], so the potential for continued
spread through mosquito transmission is extremely good.
Perhaps more concerning to many though, is the ability
for Zika to spread through sexual contact. This represents
a new route of transmission for the flaviviruses, and could
potentially increase the range for this virus to areas free
from competent mosquito vectors. So far, according to
the WHO, twelve countries have reported sexual trans-
mission [27] of Zika virus, and it is likely that this phe-
nomenon is even more widespread, yet underreported in
areas with high levels of local vector-borne transmission.
TRAVEL RELATED CASES OF ZIKA VIRUS
The vast majority of individuals infected with Zika
will never know they were infected, and even for those
who do show symptoms, they are usually relatively
mild, consisting of only a rash, headache, and general
body aches, and these patients are often afebrile [38,39].
Therefore, many people who have contracted Zika while
traveling abroad might never know that they are infect-
ed, and may not take appropriate steps to prevent sex-
ual transmission of this virus. So far, the WHO reports
that since 2015, 58 countries have reported local, mostly
mosquito-borne, transmission of this virus in the follow-
ing countries: American Samoa, Anguilla, Antigua and
Barbuda, Argentina, Aruba, Bahamas, Barbados, Belize,
Bolivia, Bonaire, Sint Eustatius and Saba – Netherlands,
Brazil, British Virgin Islands, Cabo Verde, Cayman Is-
lands, Colombia, Costa Rica, Cuba, Curaçao, Dominica,
Dominican Republic, Ecuador, El Salvador, Fiji, French
Guiana, Grenada, Guadeloupe, Guatemala, Guinea-Bis-
sau, Guyana, Haiti, Honduras, Jamaica, Marshall Islands,
Martinique, Mexico, Micronesia, Montserrat, Nicaragua,
Palau, Panama, Paraguay, Peru, Puerto Rico, Saint Bar-
thélemy, Saint Kitts and Nevis, Saint Lucia, Saint Mar-
tin, Saint Vincent and the Grenadines, Samoa, Singapore,
Sint Maarten, Suriname, Tonga, Trinidad and Tobago,
Turks and Caicos, United States of America, United
States Virgin Islands, and Venezuela [27]. Travelers re-
turning from these epidemic areas have been reported to
carry Zika virus to numerous countries including: Isra-
el [40], Italy [41], Germany [42], France [43], Norway
[44], Japan [39,45], Australia [46], Denmark [47], Can-
ada [48], and the United States [49]. It is likely though
that this list is not complete and will continue to grow as
more testing for Zika virus is performed. For this reason,
both the CDC and the WHO have issued travel warnings
for those traveling to areas where Zika transmission is
endemic, indicating the need to use insect repellant while
travelling and to use protection while engaged in sexual
activity both in these areas and also for an extended peri-
od of time after return to their home country.
TRANSMISSION OF ZIKA THROUGH
SEXUAL CONTACT
The dogma in the field has been that flaviviruses,
such as Zika, dengue, and West Nile virus, are solely vec-
tor-borne diseases requiring an insect intermediary to pass
these viruses from one person to another. Surprisingly, in
2008, a researcher at Colorado State University travelled
to Senegal and after he returned, both he and his wife,
who did not travel with him, began to experience symp-
toms that appeared to indicate an infection with dengue
virus. When his serum was tested for antibodies against
3. Hastings and Fikrig: Zika virus and sexual transmission 327
dengue, the test appeared to confirm this diagnosis, but,
curiously, when clinicians tested his wife’s serum she was
negative for dengue antibodies. The mystery remained
until two years later, when in a casual conversation about
this case with a medical entomologist from the University
of Texas Medical Branch, the possibility of a Zika virus
infection was suggested. Upon testing the serum that was
saved from 2008, it was revealed that, in fact, both the re-
searcher and his wife had been infected with Zika and not
dengue virus. This case was the first to suggest that Zika
virus was capable of transmission via the sexual route,
but at that time this virus had only been shown to be re-
sponsible for a small outbreak in Micronesia so the true
impact of this phenomena was yet to be revealed [50,51].
During the latest outbreak in the Americas, the abili-
ty for Zika to be transmitted sexually has garnered much
more attention, and many more reports of sexual trans-
mission have been documented. These cases are most-
ly from individuals who have exhibited symptoms, but
sexual transmission has also been shown from patients
that are asymptomatic at the time of sexual contact [43].
Male to female transmission is the most common [52],
but there have also been reports of sexual transmission
from female to male [53] and from male to male [54].
The increasing number of cases of sexual transmission
have led to a recommendation for abstinence or barrier
protection during sexual contact for an extended period
of time after infection with Zika virus, and further studies
have suggested that this virus is capable of persisting in
the genital tract of both males and females even after the
virus has been cleared from other areas of the host.
PERSISTENCE OF ZIKA VIRUS IN THE
GENITAL TRACT
The current recommendation by the CDC for the
prevention of sexual transmission is that abstinence is
practiced or condoms are used during sexual contact for
those returning from a Zika endemic area for at least eight
weeks for females and for at least six months for males.
These suggestions stem from numerous studies showing
persistence of Zika virus in the genital tract of both men
and women. Commensurate with the CDC recommen-
dations, this persistence has so far shown to be longer
in males, with infectious Zika able to be cultured from
semen up to 80 days after the onset of symptoms [55]
and RNA from the virus detected for at least six months
after symptoms and well after the virus could no longer
be detected in the bloodstream [56]. This phenomenon
of persistence in semen has been described previously
for two other viruses, Ebola and Rift Valley Fever virus,
which have both been detected for similar periods of time
as Zika in the seminal fluid of patients well past clearance
from the rest of the body [57,58]. For females infected
with Zika virus, infectious virus has been demonstrated
to be cleared from the vaginal tract by three weeks after
symptoms, but to persist beyond the point at which virus
can be detected in the bloodstream [59]. Further study is
underway to determine if this persistence varies by pop-
ulation group or the immune status of the individual. For
instance, in an animal model of Zika virus, it has been
demonstrated that pregnant macaques show persistent
infection despite mounting an immune response towards
this virus [60].
ANIMAL MODELS OF SEXUAL
TRANSMISSION
Other animal models of sexual transmission will be
important for determining the mechanism of Zika virus
using this route of infection and for the development of
therapeutics against Zika infection through sexual con-
tact. Similar to human infection, macaque monkeys in-
fected with Zika virus cleared virus from the blood by
10 days after infection, but viral RNA was detected in
the seminal fluid until the end of the study, three weeks
after the resolution of symptoms [61]. Another study us-
ing macaques demonstrated that Zika virus could be de-
tected in vaginal secretions even after clearance from the
bloodstream, but again phenocopied human disease in
that virus detection in the vaginal tract was not observed
to persist for as long as in the genital tract of infected
male animals [60].
The macaque model of Zika infection appears to
mimic the disease process observed in humans very well,
but is prohibitively expensive for many experiments and
not ideal for the elucidation of viral mechanisms due to
the lack of genetic manipulation. Mouse models, on the
other hand, while not as close physiologically to humans,
allow for the testing of hypotheses in an in vivo system
and are a genetically tractable model for study. Research-
ers at Yale have shown that Zika can replicate in the vagi-
nal tract of female mice, and that when pregnant mice are
infected via this route the virus is capable of spreading to
the brain of the developing fetal mice [62]. Zika infected
male mice have also been shown by multiple studies to
harbor replication of this virus in the testes. These male
mice also demonstrate a loss of serum testosterone along
with testicular atrophy and loss of sperm motility, which
raises major implications for fertility in men infected
with Zika virus [63,64].
CONCLUSION AND OUTLOOK
Sexual transmission of a virus with close relatives
that infect almost half a billion people a year is frighten-
ing, and given the fact that this virus is capable of causing
severe birth defects, you have a recipe for major head-
4. Hastings and Fikrig: Zika virus and sexual transmission328
1982;76(4):552-62.
8. Saluzzo JF, Gonzalez JP, Herve JP, Georges AJ. [Serologi-
cal survey for the prevalence of certain arboviruses in the
human population of the south-east area of Central African
Republic (author's transl)]. Bull Soc Pathol Exot Filiales.
1981;74(5):490-9.
9. Monlun E, Zeller H, Le Guenno B, Traore-Lamizana M,
Hervy JP, Adam F, et al. [Surveillance of the circulation
of arbovirus of medical interest in the region of eastern
Senegal]. Bull Soc Pathol Exot. 1993;86(1):21-8.
10. Akoua-Koffi C, Diarrassouba S, Benie VB, Ngbichi JM,
Bozoua T, Bosson A, et al. [Investigation surrounding a
fatal case of yellow fever in Cote d'Ivoire in 1999]. Bull
Soc Pathol Exot. 2001;94(3):227-30.
11. Olson JG, Ksiazek TG, Suhandiman, Triwibowo. Zika
virus, a cause of fever in Central Java, Indonesia. Trans R
Soc Trop Med Hyg. 1981;75(3):389-93.
12. Darwish MA, Hoogstraal H, Roberts TJ, Ahmed IP, Omar
F. A sero-epidemiological survey for certain arboviruses
(Togaviridae) in Pakistan. Trans R Soc Trop Med Hyg.
1983;77(4):442-5.
13. Kirya BG, Okia NO. A yellow fever epizootic in Zika For-
est, Uganda, during 1972: Part 2: Monkey serology. Trans
R Soc Trop Med Hyg. 1977;71(4):300-3.
14. Kirya BG. A yellow fever epizootic in Zika forest, Uganda,
during 1972: Part 1: Virus isolation and sentinel monkeys.
Trans R Soc Trop Med Hyg. 1977;71(3):254-60.
15. Wolfe ND, Kilbourn AM, Karesh WB, Rahman HA, Bosi
EJ, Cropp BC, et al. Sylvatic transmission of arbovirus-
es among Bornean orangutans. Am J Trop Med Hyg.
2001;64(5-6):310-6.
16. Duffy MR, Chen TH, Hancock WT, Powers AM, Kool
JL, Lanciotti RS, et al. Zika virus outbreak on Yap
Island, Federated States of Micronesia. N Engl J Med.
2009;360(24):2536-43.
17. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ,
Johnson AJ, et al. Genetic and serologic properties of Zika
virus associated with an epidemic, Yap State, Micronesia,
2007. Emerg Infect Dis. 2008;14(8):1232-9.
18. Cao-Lormeau VM, Roche C, Teissier A, Robin E, Berry
AL, Mallet HP, et al. Zika virus, French polynesia, South
pacific, 2013. Emerg Infect Dis. 2014;20(6):1085-6.
19. Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of
emerging Zika virus in the Pacific area. Clin Microbiol
Infect. 2014;20(10):0595-6.
20. Bogoch, II, Brady OJ, Kraemer MU, German M, Cre-
atore MI, Kulkarni MA, et al. Anticipating the in-
ternational spread of Zika virus from Brazil. Lancet.
2016;387(10016):335-6.
21. Salvador FS, Fujita DM. Entry routes for Zika virus in
Brazil after 2014 world cup: New possibilities. Travel Med
Infect Dis. 2015;14(1):49-51.
22. Musso D. Zika Virus Transmission from French Polynesia
to Brazil. Emerg Infect Dis. 2015;21(10):1887.
23. Simpson DI. Zika Virus Infection in Man. Trans R Soc
Trop Med Hyg. 1964;58:335-8.
24. Bearcroft WG. Zika virus infection experimentally in-
duced in a human volunteer. Trans R Soc Trop Med Hyg.
1956;50(5):442-8.
25. Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere
lines. Therefore, an important question becomes, “What
is the contribution of sexual transmission in Zika virus
outbreaks occurring across the globe?” This question can
be partially answered using mathematical modeling to an-
alyze the dynamics of disease spread for this virus. When
researchers at the National Autonomous University of
Mexico modeled recent Zika outbreaks, they found that
sexual transmission was able to affect the magnitude and
duration of the epidemics, perhaps adding only around 4
percent to the R0
(the number of new cases of Zika gener-
ated from an infected individual), but that the main driver
of the rapid spread of Zika across the globe was likely to
be migration of people. This analysis indicates that the
majority of transmission of this virus is likely to come via
the mosquito route, although in certain population groups
and in areas free from competent mosquito vectors sexual
transmission may be responsible for a significant portion
of locally transmitted cases [65]. Due to the low percent-
age of transmission attributable to sexual contact and
the previously low levels of virus circulation observed
before the most recent epidemics, it is also intriguing to
speculate that sexual transmission could have occurred in
earlier outbreaks of Zika virus without detection. Addi-
tionally, this route of transmission might actually be used
by more viruses than is currently thought, but given the
rarity of these occurrences relative to their main mode of
transmission this phenomenon is overlooked. Important
questions still remain about the mechanisms of Zika virus
in the context of sexual transmission, so it will be im-
portant to continue to study infection through this route
in both humans and animal models to determine the im-
plications on this disease overall, particularly as it relates
to pregnancy complications, viral persistence, and male
fertility.
REFERENCES
1. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations
and serological specificity. Trans R Soc Trop Med Hyg.
1952;46(5):509-20.
2. Dick GW. Zika virus. II. Pathogenicity and physical proper-
ties. Trans R Soc Trop Med Hyg. 1952;46(5):521-34.
3. Macnamara FN. Zika virus: a report on three cases of human
infection during an epidemic of jaundice in Nigeria. Trans
R Soc Trop Med Hyg. 1954;48(2):139-45.
4. Fagbami AH. Zika virus infections in Nigeria: virological
and seroepidemiological investigations in Oyo State. J Hyg
(Lond). 1979;83(2):213-9.
5. Robin Y, Mouchet J. [Serological and entomological study
on yellow fever in Sierra Leone]. Bull Soc Pathol Exot
Filiales. 1975;68(3):249-58.
6. Jan C, Languillat G, Renaudet J, Robin Y. [A serological
survey of arboviruses in Gabon]. Bull Soc Pathol Exot
Filiales. 1978;71(2):140-6.
7. McCrae AW, Kirya BG. Yellow fever and Zika virus epizo-
otics and enzootics in Uganda. Trans R Soc Trop Med Hyg.
5. Hastings and Fikrig: Zika virus and sexual transmission 329
2015;21(5):911-3.
43. Freour T, Mirallie S, Hubert B, Splingart C, Barriere
P, Maquart M, et al. Sexual transmission of Zika virus
in an entirely asymptomatic couple returning from a
Zika epidemic area, France, April 2016. Euro Surveill.
2016;21(23).
44. Waehre T, Maagard A, Tappe D, Cadar D, Schmidt-Chan-
asit J. Zika virus infection after travel to Tahiti, December
2013. Emerg Infect Dis. 2014;20(8):1412-4.
45. Shinohara K, Kutsuna S, Takasaki T, Moi ML, Ikeda M,
Kotaki A, et al. Zika fever imported from Thailand to
Japan, and diagnosed by PCR in the urines. J Travel Med.
2016;23(1).
46. Kwong JC, Druce JD, Leder K. Zika virus infection
acquired during brief travel to Indonesia. Am J Trop Med
Hyg. 2013;89(3):516-7.
47. Hamer DH, Barbre KA, Chen LH, Grobusch MP, Schla-
genhauf P, Goorhuis A, et al. Travel-Associated Zika Virus
Disease Acquired in the Americas Through February 2016:
A GeoSentinel Analysis. Ann Intern Med. 2016.
48. Fonseca K, Meatherall B, Zarra D, Drebot M, MacDonald
J, Pabbaraju K, et al. First case of Zika virus infection
in a returning Canadian traveler. Am J Trop Med Hyg.
2014;91(5):1035-8.
49. McCarthy M. First US case of Zika virus infection is iden-
tified in Texas. BMJ. 2016;352:i212.
50. Enserink M. Sex After a Field Trip Yields Scientific First.
Science. 2011.
51. Foy BD, Kobylinski KC, Chilson Foy JL, Blitvich BJ,
Travassos da Rosa A, Haddow AD, et al. Probable non-
vector-borne transmission of Zika virus, Colorado, USA.
Emerg Infect Dis. 2011;17(5):880-2.
52. D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lam-
ballerie X, Hubert B, Piorkowski G, et al. Evidence
of Sexual Transmission of Zika Virus. N Engl J Med.
2016;374(22):2195-8.
53. Davidson A, Slavinski S, Komoto K, Rakeman J, Weiss D.
Suspected Female-to-Male Sexual Transmission of Zika
Virus - New York City, 2016. MMWR Morb Mortal Wkly
Rep. 2016;65(28):716-7.
54. Deckard DT, Chung WM, Brooks JT, Smith JC, Woldai S,
Hennessey M, et al. Male-to-Male Sexual Transmission of
Zika Virus--Texas, January 2016. MMWR Morb Mortal
Wkly Rep. 2016;65(14):372-4.
55. Matheron S, d'Ortenzio E, Leparc-Goffart I, Hubert B, de
Lamballerie X, Yazdanpanah Y. Long-Lasting Persistence
of Zika Virus in Semen. Clin Infect Dis. 2016;63(9):1264.
56. Nicastri E, Castilletti C, Liuzzi G, Iannetta M, Capobianchi
MR, Ippolito G. Persistent detection of Zika virus RNA in
semen for six months after symptom onset in a traveller
returning from Haiti to Italy, February 2016. Euro Surveill.
2016;21(32).
57. Haneche F, Leparc-Goffart I, Simon F, Hentzien M,
Martinez-Pourcher V, Caumes E, et al. Rift Valley fever in
kidney transplant recipient returning from Mali with viral
RNA detected in semen up to four months from symptom
onset, France, autumn 2015. Euro Surveill. 2016;21(18).
58. Uyeki TM, Erickson BR, Brown S, McElroy AK, Cannon
D, Gibbons A, et al. Ebola Virus Persistence in Semen of
Male Survivors. Clin Infect Dis. 2016;62(12):1552-5.
S, Valour F, et al. Zika virus infection complicated by
Guillain-Barre syndrome--case report, French Polynesia,
December 2013. Euro Surveill. 2014;19(9).
26. Ioos S, Mallet HP, Leparc Goffart I, Gauthier V, Cardoso
T, Herida M. Current Zika virus epidemiology and recent
epidemics. Med Mal Infect. 2014;44(7):302-7.
27. World Health Organization. Zika Situation Report. 2016.
Epub 24 November 2016.
28. Ventura CV, Maia M, Bravo-Filho V, Gois AL, Belfort R,
Jr. Zika virus in Brazil and macular atrophy in a child with
microcephaly. Lancet. 2016;387(10015):228.
29. Schuler-Faccini L, Ribeiro EM, Feitosa IM, Horovitz
DD, Cavalcanti DP, Pessoa A, et al. Possible Association
Between Zika Virus Infection and Microcephaly - Brazil,
2015. MMWR Morb Mortal Wkly Rep. 2016;65(3):59-62.
30. Triunfol M. A new mosquito-borne threat to pregnant
women in Brazil. Lancet Infect Dis. 2015;16(2):156-7.
31. Eisen L, Moore CG. Aedes (Stegomyia) aegypti in the
continental United States: a vector at the cool margin of its
geographic range. J Med Entomol. 2013;50(3):467-78.
32. Kraemer MU, Sinka ME, Duda KA, Mylne AQ, Shear-
er FM, Barker CM, et al. The global distribution of the
arbovirus vectors Aedes aegypti and Ae. albopictus. Elife.
2015;4:e08347.
33. Huang YJ, Higgs S, Horne KM, Vanlandingham DL. Flavi-
virus-mosquito interactions. Viruses. 2014;6(11):4703-30.
34. Lambrechts L, Scott TW, Gubler DJ. Consequences of
the expanding global distribution of Aedes albopictus
for dengue virus transmission. PLoS Negl Trop Dis.
2010;4(5):e646.
35. Guagliardo SA, Barboza JL, Morrison AC, Astete H,
Vazquez-Prokopec G, Kitron U. Patterns of geographic
expansion of Aedes aegypti in the Peruvian Amazon. PLoS
Negl Trop Dis. 2014;8(8):e3033.
36. Diaz-Nieto LM, Macia A, Perotti MA, Beron CM. Geo-
graphical limits of the Southeastern distribution of Aedes
aegypti (Diptera, Culicidae) in Argentina. PLoS Negl Trop
Dis. 2013;7(1):e1963.
37. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW,
Moyes CL, et al. The global distribution and burden of
dengue. Nature. 2013;496(7446):504-7.
38. Ginier M, Neumayr A, Gunther S, Schmidt-Chanasit
J, Blum J. Zika without symptoms in returning travel-
lers: What are the implications? Travel Med Infect Dis.
2016;14(1):16-20.
39. Kutsuna S, Kato Y, Takasaki T, Moi M, Kotaki A, Uemura
H, et al. Two cases of Zika fever imported from French
Polynesia to Japan, December 2013 to January 2014 [cor-
rected]. Euro Surveill. 2014;19(4).
40. Meltzer E, Lustig Y, Leshem E, Levy R, Gottesman
G, Weissmann R, et al. Zika Virus Disease in Traveler
Returning from Vietnam to Israel. Emerg Infect Dis.
2016;22(8):1521-2.
41. Zammarchi L, Stella G, Mantella A, Bartolozzi D, Tappe
D, Gunther S, et al. Zika virus infections imported to Italy:
clinical, immunological and virological findings, and pub-
lic health implications. J Clin Virol. 2015;63:32-5.
42. Tappe D, Nachtigall S, Kapaun A, Schnitzler P, Gunther S,
Schmidt-Chanasit J. Acute Zika virus infection after travel
to Malaysian Borneo, September 2014. Emerg Infect Dis.
6. Hastings and Fikrig: Zika virus and sexual transmission330
59. Prisant N, Breurec S, Moriniere C, Bujan L, Joguet G.
Zika Virus Genital Tract Shedding in Infected Women of
Childbearing age. Clin Infect Dis. 2016.
60. Dudley DM, Aliota MT, Mohr EL, Weiler AM, Leh-
rer-Brey G, Weisgrau KL, et al. A rhesus macaque model
of Asian-lineage Zika virus infection. Nature Communica-
tions. 2016;7:12204.
61. Osuna CE, Lim SY, Deleage C, Griffin BD, Stein D, Schro-
eder LT, et al. Zika viral dynamics and shedding in rhesus
and cynomolgus macaques. Nat Med. 2016.
62. Yockey LJ, Varela L, Rakib T, Khoury-Hanold W,
Fink SL, Stutz B, et al. Vaginal Exposure to Zika Virus
during Pregnancy Leads to Fetal Brain Infection. Cell.
2016;166(5):1247-56 e4.
63. Govero J, Esakky P, Scheaffer SM, Fernandez E, Drury A,
Platt DJ, et al. Zika virus infection damages the testes in
mice. Nature. 2016.
64. Ma W, Li S, Ma S, Jia L, Zhang F, Zhang Y, et al. Zika
Virus Causes Testis Damage and Leads to Male Infertility
in Mice. Cell. 2016. Epub 2016/11/26.
65. Baca-Carrasco D, Velasco-Hernandez JX. Sex, Mosquitoes
and Epidemics: An Evaluation of Zika Disease Dynamics.
Bull Math Biol. 2016;78(11):2228-42.